Puma Biotech (PBYI) – Management Comments
-
Puma Biotech (PBYI) Tops Q4 EPS by 15c
-
Puma Biotech (PBYI) Announces Interim Results from the Biliary Tract Cancers Cohort of the Phase II SUMMIT 'Basket' Trial of Neratinib
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PBYI Stock Lookup